Home > Healthcare > Medical Devices > Medical Supplies > U.S. Ophthalmic Sutures Market

U.S. Ophthalmic Sutures Market Size

Report ID: GMI4517
Published Date: Dec 2022
Report Format: PDF

Download Free Sample

U.S. Ophthalmic Sutures Market Size

U.S. Ophthalmic Sutures Market Size was valued at more than USD 296 million in 2022 and is expected to observe a 5.5% CAGR through 2032. Growing prevalence of eye diseases in the U.S. is anticipated to expedite the market growth in the coming years.

To get key market trends

Download Free Sample

Disorders such as cataract, glaucoma, and detached retina have added to the eye disease burden in the region. As per the National Eye Institute, around 24 million Americans are presently suffering from cataract and an estimated 38.7 million will be affected by the disease by 2030. Usually, surgeries are recommended to treat such severe eye diseases to improve vision. Hence, these diseases are contributing to the demand for ophthalmic suture products that provide optimum outcomes in related surgical procedures.

U.S. Ophthalmic Sutures Market Report Attributes
Report Attribute	Details
Base Year:	2022
U.S. Ophthalmic Sutures Market Size in 2022:	USD 296.5 million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	5.5%
2032 Value Projection:	USD 543.6 million
Historical Data for:	2018 to 2022
No. of Pages:	90
Tables, Charts & Figures:	74
Segments covered:	Type, Materials, Coating, Material Structure, Absorption, Application, End-use, and Region.
Growth Drivers:	Growing prevalence of eye disease Technological advancements Growing prevalence of diabetes leading to ophthalmic disorders Favorable government initiatives Growing demand and preference for minimally invasive surgeries
Pitfalls & Challenges:	Postoperative complications associated with ophthalmic procedures Lack of skilled ophthalmologist

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

U.S. market for ophthalmic sutures was valued at over USD 296 million in 2022 and is projected to observe a 5.5% CAGR through 2032, owing to the growing prevalence of eye diseases in the region.

Demand for natural ophthalmic sutures in the U.S. is expected to reach around USD 163 million through 2032, thanks to the adequate strength, self-degradation absorption, and non-irritating carcinogenic characteristics of the product.

U.S. ophthalmic sutures industry share from the hospital segment is projected to reach USD 297 million through 2032, with better healthcare infrastructure and professional aid offered by these institutions.

Some prominent companies operating in the regional market include Medtronic, Mani, Corzamedical, Teleflex Incorporated, Ethicon, B Braun Melsungen AG, and DemeTECH Corporation among others.